Opioids Market Overview to 2023 - Opioids in Emerging Markets Big Market Research “Opioids Market Overview to 2023 - Opioids in Emerging Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2023. Visit for more info @ Read more details at: http://www.bigmarketresearch.com/opioids-overview-to-2023-opioids-in-emerging-market The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential.
Global opioid use disorder (oud) market size is expected to reach $6.04 Bn by 2028 at a rate of 11.3%, segmented as by drug type, buprenorphine, naltrexone, methadone
According to the latest research report by IMARC Group, The United States neuromodulation market size is projected to exhibit a growth rate (CAGR) of 11.50% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-neuromodulation-market
According to the latest research report by IMARC Group, The global gene therapy market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.8 Billion by 2032, exhibiting a growth rate (CAGR) of 13.9% during 2024-2032. More Info:- https://www.imarcgroup.com/gene-therapy-market
According to the latest research report by IMARC Group, The global drug abuse testing market size reached US$ 7.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032. More Info:- https://www.imarcgroup.com/drug-abuse-testing-market
According to the latest research report by IMARC Group, The global addiction treatment market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.76% during 2024-2032. More Info:- https://www.imarcgroup.com/addiction-treatment-market
According to the latest research report by IMARC Group, The global mucosal atomization devices market size reached US$ 772.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,300.7 Million by 2032, exhibiting a growth rate (CAGR) of 5.92% during 2024-2032. More Info:- https://www.imarcgroup.com/mucosal-atomization-devices-market
According to the latest research report by IMARC Group, The global methadone market size reached US$ 126.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 195.6 Million by 2032, exhibiting a growth rate (CAGR) of 4.95% during 2024-2032. More Info:- https://www.imarcgroup.com/methadone-market
According to the latest research report by IMARC Group, The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. More Info:- https://www.imarcgroup.com/gene-therapy-market
According to the latest research report by IMARC Group, The global drug screening market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028. More Info:- https://www.imarcgroup.com/drug-screening-market
Analyze Future: Opioids Market Overview to 2023 - Opioids in Emerging Markets To Get More Details at: http://www.analyzefuture.com/opioids-overview-to-2023-opioids-in-emerging-market The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted under strict drug control policies and regulations overseeing controlled medicines due to their high abuse potential.
According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).
According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).
The global medical cannabis market size reached US$ 31.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 57.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.47% during 2023-2028. More info: https://www.imarcgroup.com/medical-cannabis-market
Opioids in Emerging Markets covers the major emerging markets of Argentina, Brazil, China, India, Mexico, Russia, and South Africa Enquiry about report: http://www.researchbeam.com/opioids-overview-to-2023-opioids-in-emerging-market/enquire-about-report
The global opioids drugs market is anticipated to grow at a CAGR of 2.52% between 2019 and 2027. Opioids are narcotic drugs and mostly directed for pain management. Increasing case of road accidents & surgical procedures are the main drivers that are propagating the global market growth for opioids drugs
Demand for synthetic opioids continues to witness a decline in North America. According to a new research from Persistence Market Research, the US$ 75 billion synthetic opioids market will grow at a sluggish 2.4% during the period 2016-2024.
Big Market Research “Global Opioid-Induced Constipation Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-opioid-induced-constipation-2015-2019-market Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents.
TBRC’s Analgesics Market Comprehensive Research, gives an expert analysis on the industry in order to provide key insights and global status. https://bit.ly/3sUEf6d
The global market size of Cancer Pain is $XX million in 2019 with XX CAGR from 2015 to 2019, and it is expected to reach $XX million by the end of 2025 with a CAGR of XX% from 2020 to 2025.
According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).
Cluster headache is a neurological disorder which is characterized by serious headaches periodically on one side of the head generally around the eye. Cluster headache is frequently accompanied by autonomic symptoms like excessive tears, swelling of the eye and nasal decongestion.
According to the revised report published by Persistence Market Research, the global opioids market valued at US$ 40.5 Bn in 2020, and is predicted to expand at a CAGR of 3% over the forecast period (2021–2031).
Opioid use disorder refers to a condition in which patients are addicted/dependent on the consumption of opioids and generally related to environmental and genetic factors resulting in it arising in patients. The disorder is segregated into two categories, including opioids available as non-medicinal and patients reliant on medicinal opioid drugs.
Global cluster headaches market is set to witness a steady CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing healthcare awareness and rising demand for diagnosis of cluster headache is the factor for the growth of this market.
Transcutaneous electrical nerve stimulators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to grow at a CAGR of 4.11% in the above-mentioned forecast period. Increasing adoption of transcutaneous electrical nerve stimulators by the emerging countries drives the acetaminophen (Paracetamol) market.
One of the biggest challenge faced by prescriber of drugs is that every individual requires different levels of tolerance and variable opioid doses to obtain adequate pain relief. Controlled substances are medications or illicit drugs which are active in the central nervous system and can potentially cause a relative physical and mental dependence which can lead to addiction of those drugs.
The global medical cannabis market size is expected to reach USD 24.52 Billion at a steady revenue CAGR of 11.5% in 2028, according to latest analysis by Emergen Research. Increase in medical cannabis products and the rise in research activities are driving the market revenue growth. Moreover, legalization of the product in several countries is also propelling growth of the market.
Diabetic Neuropathy is a nerve damage condition caused by prolonged elevated levels of blood sugar. It is most commonly observed in individuals with diabetes and can lead to various complications such as peripheral neuropathy, autonomic neuropathy, and proximal neuropathy
The global cancer supportive care drugs market was valued at approximately US$ 14.3 billion in 2022 and is projected to grow at a CAGR of 1.7% from 2023 to 2031, reaching over US$ 16.7 billion by the end of the forecast period.
Big Market Research adds a report “Cancer Pain Therapeutics Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2019" Get Complete Report http://www.bigmarketresearch.com/global-cancer-pain-therapeutics-market To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of cancer pain. Cancer Pain Therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/385296
The global pain management market was valued at US$ 3,691.2 million in 2020 and is expected to reach US$ 5,786.9 billion by 2028; growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2021 – 2028. Pain Management refers to the branch of medicine care which helps in reducing the pain by prevention, diagnosis and treatment of pain. Pain management devices are referred as the medical devices which are used for pain management such as cancer pain, neuropathic pain, musculoskeletal pain, nociceptive pain and others. Neurostimulation, infusion pumps and electric stimulation are the widely prescribed devices by physicians to eliminate chronic pain.
Cancer is a leading cause of global death, which nearly caused 10 million deaths in 2020. The treatment of cancer typically includes chemotherapy, hormone therapy, immunotherapy, gene therapy, radiotherapy, and targeted therapy. However, in some of the cases, patients do not respond to any of the available treatment options or develop resistance to available therapies. This creates a lacuna, which in turn creates an opportunity for the scientific community to develop a keen interest in Intratumoral Cancer Therapies that are immunotherapies and the immunization is administered directly into tumour’s through injections. By filling this lacuna of cancer treatment, immunotherapy has evolved and had come a long way with its benefits and possesses advantages over conventional cancer treatment methods, which is widely accepted.
Anti-infectives are medications that help in preventing and treating infections, such as anti-bacterial, anti-viral, anti-fungal, and antiparasitic medications. Anti-infective therapies help in the treatment of minor infections and many serious infectious diseases such as tuberculosis and pneumonia. These therapies have revolutionized healthcare as they enrich and extend the life of patients suffering from all types of infectious diseases.
Persistence Market Research has delivered key insights and presented a revised forecast of the global sterile injectable drugs market for a period of 8 years from 2017 to 2025. The revision in the market size and forecasts have been carried out taking into account the impact of various macroeconomic indicators and other industry-based factors driving the demand, as well as the recent developments of key market participants.
Global topical pain relief market size is expected to reach $13.68 Bn by 2028 at a rate of 6.2%, segmented as by type, prescription pain relief, over-the-counter (otc) pain relief
Opioid Withdrawal Treatment is the medical and psychological care of patients who are experiencing withdrawal symptoms as a result of ceasing or reducing the use of their drug of dependence. This treatment is used on the patients who are dependent on opioids such as illegal drug heroin, fentanyl, pain relievers, etc to overcome brutal pains or chronic pains
The global analgesic market size is estimated to be $26.462.5 billion as of 2018. With catapulting incidences of inflammation, physiological injury, cancer treatments, neuropathic conditions, surgeries, wounds, and phantom aches amalgamated with escalating geriatric population
According to the Market Statsville Group (MSG), the global analgesics market size is expected to grow from USD 31.6 billion in 2023 to USD 61.0 billion by 2033, at a CAGR of 6.8% from 2023 to 2033. The analgesics market is a vital segment of the pharmaceutical industry, encompassing a diverse range of pain-relieving medications. These drugs, available both over-the-counter and by prescription,
The Pain Relief Patches Market, valued at US$ 1.2 billion in 2024, is projected to grow to US$ 1.9 billion by 2032, with a compound annual growth rate (CAGR) of 4.9%, according to a recent study by Persistence Market Research. Non-steroidal anti-inflammatory drug patches dominate the market with a leading share of 39.5%. In 2021, pain relief patches held 15% of the global transdermal patches market. Nanotechnology integration in pharmaceuticals has boosted sales, with various nanomaterials approved for medical use. A study on Kailo pain patch showed a 71% reduction in pain severity, cited in Anesthesia & Pain Research. Market size was $1.1B in 2023, estimated $1.2B in 2024, and forecasted $1.9B in 2032, with top 5 countries holding 54.2% market share.